vs
ARDELYX, INC.（ARDX）与AerSale Corp（ASLE）财务数据对比。点击上方公司名可切换其他公司
ARDELYX, INC.的季度营收约是AerSale Corp的1.0倍（$94.5M vs $90.9M），AerSale Corp净利率更高（5.9% vs -39.8%，领先45.7%），ARDELYX, INC.同比增速更快（27.5% vs -4.0%），过去两年ARDELYX, INC.的营收复合增速更高（13.6% vs 0.2%）
Ardelyx是一家商业化阶段的生物制药企业，专注于研发和商业化针对胃肠道、心肾及代谢类疾病的创新疗法，其核心产品已在美国获批用于治疗便秘型肠易激综合征，同时拥有涵盖多适应症的各阶段研发管线。
AerSale Corp总部位于美国佛罗里达州多拉市，是一家面向航空领域的全球供应商，主要为客运及货运航空公司、政府机构、跨国整机制造商与独立维修机构提供商用喷气飞机二手整机、发动机、航空耗材，并提供航空工程服务，同时该公司也是飞机机队回收协会的成员企业。
ARDX vs ASLE — 直观对比
营收规模更大
ARDX
是对方的1.0倍
$90.9M
营收增速更快
ARDX
高出31.5%
-4.0%
净利率更高
ASLE
高出45.7%
-39.8%
两年增速更快
ARDX
近两年复合增速
0.2%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $94.5M | $90.9M |
| 净利润 | $-37.6M | $5.4M |
| 毛利率 | — | 34.1% |
| 营业利润率 | — | 7.8% |
| 净利率 | -39.8% | 5.9% |
| 营收同比 | 27.5% | -4.0% |
| 净利润同比 | — | 99.7% |
| 每股收益（稀释后） | $-0.15 | $0.10 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ARDXASLE
| Q1 26 | $94.5M | — | ||
| Q4 25 | $125.2M | $90.9M | ||
| Q3 25 | $110.3M | $71.2M | ||
| Q2 25 | $97.7M | $107.4M | ||
| Q1 25 | $74.1M | $65.8M | ||
| Q4 24 | $116.1M | $94.7M | ||
| Q3 24 | $98.2M | $82.7M | ||
| Q2 24 | $73.2M | $77.1M |
净利润ARDXASLE
| Q1 26 | $-37.6M | — | ||
| Q4 25 | $-407.0K | $5.4M | ||
| Q3 25 | $-969.0K | $-120.0K | ||
| Q2 25 | $-19.1M | $8.6M | ||
| Q1 25 | $-41.1M | $-5.3M | ||
| Q4 24 | $4.6M | $2.7M | ||
| Q3 24 | $-809.0K | $509.0K | ||
| Q2 24 | $-16.5M | $-3.6M |
毛利率ARDXASLE
| Q1 26 | — | — | ||
| Q4 25 | 91.3% | 34.1% | ||
| Q3 25 | 96.4% | 30.2% | ||
| Q2 25 | 87.3% | 32.9% | ||
| Q1 25 | 83.4% | 27.3% | ||
| Q4 24 | 84.3% | 31.4% | ||
| Q3 24 | 84.0% | 28.6% | ||
| Q2 24 | 87.1% | 28.2% |
营业利润率ARDXASLE
| Q1 26 | — | — | ||
| Q4 25 | 4.1% | 7.8% | ||
| Q3 25 | 4.2% | 4.0% | ||
| Q2 25 | -14.7% | 11.7% | ||
| Q1 25 | -49.0% | -10.1% | ||
| Q4 24 | 7.0% | 5.2% | ||
| Q3 24 | 2.3% | 2.4% | ||
| Q2 24 | -18.6% | -2.4% |
净利率ARDXASLE
| Q1 26 | -39.8% | — | ||
| Q4 25 | -0.3% | 5.9% | ||
| Q3 25 | -0.9% | -0.2% | ||
| Q2 25 | -19.5% | 8.0% | ||
| Q1 25 | -55.5% | -8.0% | ||
| Q4 24 | 4.0% | 2.9% | ||
| Q3 24 | -0.8% | 0.6% | ||
| Q2 24 | -22.5% | -4.7% |
每股收益（稀释后）ARDXASLE
| Q1 26 | $-0.15 | — | ||
| Q4 25 | $-0.01 | $0.10 | ||
| Q3 25 | $0.00 | $0.00 | ||
| Q2 25 | $-0.08 | $0.18 | ||
| Q1 25 | $-0.17 | $-0.10 | ||
| Q4 24 | $0.01 | $0.05 | ||
| Q3 24 | $0.00 | $0.01 | ||
| Q2 24 | $-0.07 | $-0.07 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $238.1M | $4.4M |
| 总债务越低越好 | $203.5M | $1.3M |
| 股东权益账面价值 | $148.6M | $424.4M |
| 总资产 | $504.5M | $640.5M |
| 负债/权益比越低杠杆越低 | 1.37× | 0.00× |
8季度趋势，按日历期对齐
现金及短期投资ARDXASLE
| Q1 26 | $238.1M | — | ||
| Q4 25 | $68.0M | $4.4M | ||
| Q3 25 | $42.7M | $5.3M | ||
| Q2 25 | $90.0M | $5.7M | ||
| Q1 25 | $30.8M | $4.7M | ||
| Q4 24 | $64.9M | $4.7M | ||
| Q3 24 | $47.4M | $9.8M | ||
| Q2 24 | $41.9M | $4.3M |
总债务ARDXASLE
| Q1 26 | $203.5M | — | ||
| Q4 25 | $202.8M | $1.3M | ||
| Q3 25 | $202.1M | $1.5M | ||
| Q2 25 | $201.4M | $907.0K | ||
| Q1 25 | $151.3M | $1.1M | ||
| Q4 24 | $150.9M | $1.2M | ||
| Q3 24 | $100.7M | $376.0K | ||
| Q2 24 | $100.2M | $522.0K |
股东权益ARDXASLE
| Q1 26 | $148.6M | — | ||
| Q4 25 | $166.9M | $424.4M | ||
| Q3 25 | $154.3M | $417.1M | ||
| Q2 25 | $139.5M | $415.9M | ||
| Q1 25 | $145.7M | $406.5M | ||
| Q4 24 | $173.3M | $455.6M | ||
| Q3 24 | $158.3M | $451.5M | ||
| Q2 24 | $147.0M | $449.8M |
总资产ARDXASLE
| Q1 26 | $504.5M | — | ||
| Q4 25 | $501.6M | $640.5M | ||
| Q3 25 | $486.2M | $646.3M | ||
| Q2 25 | $466.8M | $646.7M | ||
| Q1 25 | $410.2M | $646.1M | ||
| Q4 24 | $435.8M | $604.7M | ||
| Q3 24 | $367.9M | $601.5M | ||
| Q2 24 | $343.5M | $598.7M |
负债/权益比ARDXASLE
| Q1 26 | 1.37× | — | ||
| Q4 25 | 1.21× | 0.00× | ||
| Q3 25 | 1.31× | 0.00× | ||
| Q2 25 | 1.44× | 0.00× | ||
| Q1 25 | 1.04× | 0.00× | ||
| Q4 24 | 0.87× | 0.00× | ||
| Q3 24 | 0.64× | 0.00× | ||
| Q2 24 | 0.68× | 0.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $11.4M |
| 自由现金流经营现金流 - 资本支出 | — | $9.8M |
| 自由现金流率自由现金流/营收 | — | 10.8% |
| 资本支出强度资本支出/营收 | — | 1.7% |
| 现金转化率经营现金流/净利润 | — | 2.11× |
| 过去12个月自由现金流最近4个季度 | — | $-29.1M |
8季度趋势，按日历期对齐
经营现金流ARDXASLE
| Q1 26 | — | — | ||
| Q4 25 | $21.0M | $11.4M | ||
| Q3 25 | $365.0K | $-8.9M | ||
| Q2 25 | $-25.3M | $19.8M | ||
| Q1 25 | $-38.5M | $-45.2M | ||
| Q4 24 | $9.8M | $37.5M | ||
| Q3 24 | $501.0K | $10.4M | ||
| Q2 24 | $-19.4M | $-15.3M |
自由现金流ARDXASLE
| Q1 26 | — | — | ||
| Q4 25 | $20.6M | $9.8M | ||
| Q3 25 | $209.0K | $-9.8M | ||
| Q2 25 | $-26.0M | $18.6M | ||
| Q1 25 | $-38.8M | $-47.6M | ||
| Q4 24 | $9.2M | $32.3M | ||
| Q3 24 | $364.0K | $8.9M | ||
| Q2 24 | $-19.5M | $-18.9M |
自由现金流率ARDXASLE
| Q1 26 | — | — | ||
| Q4 25 | 16.4% | 10.8% | ||
| Q3 25 | 0.2% | -13.8% | ||
| Q2 25 | -26.6% | 17.3% | ||
| Q1 25 | -52.3% | -72.4% | ||
| Q4 24 | 7.9% | 34.0% | ||
| Q3 24 | 0.4% | 10.7% | ||
| Q2 24 | -26.7% | -24.6% |
资本支出强度ARDXASLE
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | 1.7% | ||
| Q3 25 | 0.1% | 1.3% | ||
| Q2 25 | 0.7% | 1.1% | ||
| Q1 25 | 0.4% | 3.7% | ||
| Q4 24 | 0.5% | 5.6% | ||
| Q3 24 | 0.1% | 1.9% | ||
| Q2 24 | 0.2% | 4.7% |
现金转化率ARDXASLE
| Q1 26 | — | — | ||
| Q4 25 | — | 2.11× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 2.31× | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.11× | 13.89× | ||
| Q3 24 | — | 20.52× | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ARDX
| IBSRELA | $70.1M | 74% |
| XPHOZAH | $23.3M | 25% |
| Non-cash royalty revenue related to the sale of future royalties | $695.0K | 1% |
| Product supply revenue | $354.0K | 0% |
ASLE
| Products | $57.8M | 64% |
| Maintenance | $23.2M | 26% |
| Leasing Arrangements | $9.9M | 11% |
